Vaccines for preventing influenza in people with cystic fibrosis

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Dharmaraj, Poonam ^a   Smyth, Rosalind L ^b  

^a Alder Hey Children's Foundation Trust   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

*Influenza vaccines; Adolescent; Child; Child, preschool; Cystic fibrosis *complications ; Humans; Infant; Influenza, human *prevention control ; Randomized controlled trials as topic; Vaccines, attenuated; Vaccines, inactivated

Indexed keywords

PSEUDOMONAS VACCINE;

ANTIBODY TITER; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG EFFECT; DRUG SAFETY; HUMAN; INFECTION PREVENTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVIEW; UNSPECIFIED SIDE EFFECT; VACCINATION;

EID: 77950112873     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001753.pub2     Document Type: Review

References (27)

1. Adlard 1987 {published data only} Adlard P, Bryett K. Influenza immunisation in children with cystic fibrosis. Journal of International Medical Research 1987;15(6): 344-51.
2. Gruber 1994 {published data only} Gruber WC, Campbell PW, Thompson JM, Reed GW, Roberts B, Wright PF. Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: Results of a 3 year study. Journal of Infectious Diseases 1994;169(2):241-7.
3. King 1987 {published data only} King JC, Gross PA, Denning CR, Gaerlin PF, Wright PF, Quinnan GV. Comparison of live and inactivated influenza vaccine in high risk children. Vaccine 1987;5(3):234-8.
4. Schaad 2000 {published data only} * Schaad UB, Bühlmann U, Burger R, Ruedeberg A, Wilder-Smith A, Rutishauser M, et al.Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis.. Antimicrobial Agents and Chemotherapy 2000;44(5):1163- 7.
5. Schadd UB, Buehlmann U, Burger R,Wilder-Smtih A, Rutishauser M, Sennhauser FH, et al.Comparison of immunogenicity and safety of a virosome and a subunit influenza vaccine in pediatric cystic fibrosis (CF) patients: A Swiss multicenter study [abstract]. Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1997 Sept 28 -Oct 01. 1997:238.
6. Doudounakis 2000 {unpublished data only} Doudounakis S, Velenzas P, Sophianos D, Kikis G, Theodoridou M, Adam G. Comparison of two vaccination schemes against influenza in children with cystic fibrosis [abstract]. Proceedings of the XIIth International Cystic Fibrosis Congress; 2000 June 4-8; Stockholm. 2000:169.
7. Doudounakis S, Velenzas P, Sophianos D, Kikis G, Theodoridou M, Adam G. Efficacy of two different vaccination schemes for influenza annual vaccination in cystic fibrosis patients 3 - 8 years old [abstract]. European Respiratory Journal 2001;18(33):539s.
8. Ong 1991 {published data only} Ong ELC, Bilton D, Abbott J, Webb AK, McCartney RA, Caul EO. Influenza vaccination in adults with cystic fibrosis. BMJ 1991; 303(6802):557.
9. Ashley 1991 Ashley J, Smith T, Dunnel K. Deaths in Great Britain with the influenza epidemic of 1989/1990. Population Trends 1991;62: 16-20.
10. Bernstein 1982 Bernstein DI, Zahradnik JM, DeAngelis CJ, Cherry JD. Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines. American Journal of Diseases of Children 1982;136(6):513-7.
11. CDC 1999 Centers for Disease Control. Prevention and control of influenza: recommendation of the advisory committee on immunisation practices. Morbidity and Mortality Weekly Report 1999;48(RR - 4): 1-49.
12. Collinson 1996 Collinson J, Nicholson KG, Cancio E, Ashman J, Ireland DC, Hammersley V, et al.Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax 1996;51(11):1115-22.
13. Conway 1992 Conway SP, Simmonds EJ, Littlewood JM. Acute severe deterioration in cystic fibrosis associated with influenza A virus infection. Thorax 1992;47(2):112-4.
14. Ferson 1991 Ferson MJ, Morton JR, Robertson PW. Impact of influenza on morbidity in children with cystic fibrosis. Journal of Paediatric Child Health 1991;27(5):308-11.
15. Higgins 2003 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60.
16. HMSO 1996 Department of Health, Welsh Office, Scottish Office, DHSS (Northern Ireland). Influenza. In: Salisbury DM, Begg NT editor (s). Immunisation against infectious disease (Green Book). London: HMSO, 1996:113-20.
17. Holm 1999 Holm KJ, Goa KL. Liposomal Influenza Vaccine. BioDrugs 1999; 11(2):137-44.
18. Jadad 1996 Jadad A, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, et al.Assessing the quality of reports of randomised controlled trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
19. Johansen 1992 Johansen HK, Hoiby N. Seasonal onset of initial colonisation and chronic infections with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 1992;47(2):109-11.
20. McElhaney 1993 McElhaney JE, Meneilly GS, Lechelt KE, Beattie BL, Bleackley RC. Antibody response to whole-virus and split-virus influenza vaccines in successful ageing. Vaccine 1993;11(10):1055-60.
21. Petersen 1981 Petersen NT, Hoiby N, Mordhorst CH, Lind K, Flensborg EW, Bruun B. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma - possible synergism with Pseudomonas aeruginosa. Acta Paediatrica Scandinavia 1981;70(5): 623-8.
22. Ramsey 1989 Ramsey BW, Gore EJ, Smith AL, Cooney MK, Redding GJ, Foy H. The effect of respiratory viral infections on patients with cystic fibrosis. American Journal of Diseases of Children 1989;143(6): 662-8.
23. RevMan 2008 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
24. RLCH Pharmacy 2009 Royal Liverpool Children's Hospital Pharmacy. Personal communication 22 July 2009.
25. Ryan 1997 Ryan F, Shortt C, Bredin C, Watson JB, O'Halloran T. The use of influenza vaccine in patients with cystic fibrosis. Irish Medical Journal 1997;90(8):293.
26. Smyth 1995 Smyth AR, Smyth RL, Tong CY, Hart CA, Heaf DP. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Archives of Disease in Childhood 1995;73(2):117- 20.
27. Wang 1984 Wang EE, Prober CG, Manson B, Corey M, Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. New England Journal of Medicine 1984;311(26):1653-8.